Genome-scale reconstruction and in silico analysis of Klebsiella oxytoca for 2,3-butanediol production by Jong Myoung Park et al.
Park et al. Microbial Cell Factories 2013, 12:20
http://www.microbialcellfactories.com/content/12/1/20RESEARCH Open AccessGenome-scale reconstruction and in silico analysis
of Klebsiella oxytoca for 2,3-butanediol production
Jong Myoung Park, Hyohak Song*, Hee Jong Lee and Doyoung SeungAbstract
Background: Klebsiella oxytoca, a Gram-negative, rod-shaped, and facultative anaerobic bacterium, is one of the
most promising 2,3-butanediol (2,3-BD) producers. In order to improve the metabolic performance of K. oxytoca as
an efficient biofactory, it is necessary to assess its metabolic characteristics with a system-wide scope, and to
optimize the metabolic pathways at a systems level. Provision of the complete genome sequence of K. oxytoca
enabled the construction of genome-scale metabolic model of K. oxytoca and its in silico analyses.
Results: The genome-scale metabolic model of K. oxytoca was constructed using the annotated genome with
biochemical and physiological information. The stoichiometric model, KoxGSC1457, is composed of 1,457 reactions
and 1,099 metabolites. The model was further refined by applying biomass composition equations and comparing
in silico results with experimental data based on constraints-based flux analyses. Then, the model was applied to in
silico analyses to understand the properties of K. oxytoca and also to improve its capabilities for 2,3-BD production
according to genetic and environmental perturbations. Firstly, in silico analysis, which tested the effect of
augmenting the metabolic flux pool of 2,3-BD precursors, elucidated that increasing the pyruvate pool is primarily
important for 2,3-BD synthesis. Secondly, we performed in silico single gene knockout simulation for 2,3-BD
overproduction, and investigated the changes of the in silico flux solution space of a ldhA gene knockout mutant in
comparison with that of the wild-type strain. Finally, the KoxGSC1457 model was used to optimize the oxygen
levels during fermentation for 2,3-BD production.
Conclusions: The genome-scale metabolic model, KoxGSC1457, constructed in this study successfully investigated
metabolic characteristics of K. oxytoca at systems level. The KoxGSC1457 model could be employed as an useful
tool to analyze its metabolic capabilities, to predict its physiological responses according to environmental and
genetic perturbations, and to design metabolic engineering strategies to improve its metabolic performance.Background
There is growing interest in the production of 2,3-
butanediol (2,3-BD) by microbial fermentation, as it can
be easily converted to methyl ethyl ketone and tetramethyl
ether, blending agents for gasoline, and 1,3-butadiene,
an intermediate in synthetic rubber manufacture [1-4].
Klebsiella oxytoca is known as one of the most promising
2,3-BD producers [1-10], and its whole genome sequences
have been reported recently. The genome of K. oxytoca
KCTC1686 consists of a chromosome of 5,974,109 bp with
a 56.05% GC content, including 5,488 coding genes [11].
The genome of K. oxytoca E718 is composed of a chromo-
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reproduction in any medium, provided the or110,781 bp with a 55.5% GC content, including 5,909 co-
ding genes [12]. More recently, we isolated K. oxytoca
KCTC12133BP from a cattle farm and sequenced its
whole genome, but the sequence information, which has
not yet been published, consists of a chromosome of
5,903,932 bp and a plasmid of 109,773 bp with a 55.4%
GC content, including 5,793 coding genes.
The most important characteristics of K. oxytoca is to
produce large amounts of C3/C4 diols, 1,3-propanediol
(1,3-PD) and 2,3-BD, using various carbon sources
[10,13-20]. For example, a lactate deficient mutant of
K. oxytoca coproduced 83.6 and 60.1 g/L of 1,3-PD and
2,3-BD, respectively, in a fed-batch fermentation utilizing
mixed substrates of glycerol and sucrose [13]. K. oxytoca
also could produce more than 95 g/L of 2,3-BD from glu-
cose with a yield of 0.478 g/g (95.6% of the theoretical. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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batch fermentation, in which the agitation speed was
switched from 300 to 200 rpm during the fermentation
[10]. The availability of oxygen to K. oxytoca significantly
affects its physiology and 2,3-BD production [21-23].
Another striking aspect of K. oxytoca is to readily
metabolize glycerol, an inevitable by-product of biodiesel
production, into biomass and products of value [13,24,25].
The aforementioned advantages make K. oxytoca an
attractive host for industrial applications. Furthermore,
the U.S. National Institute of Health (NIH, Guidelines
for Research Involving Recombinant DNA Molecules,
2002) has reported that K. oxytoca belongs to risk group
1 (RG 1), recognizing it as a GRAS (Generally Regarded
As Safe) organism. However, in order to use this organism
on an industrial scale, the strain should be further deve-
loped. Systems metabolic engineering allows the rational
design of metabolic networks for the overproduction of
target compounds and the creation of industrially useful
microorganisms [26-31]. Here, and in silico genome-scale
metabolic model of K. oxytoca, KoxGSC1457, was cons-
tructed based on genome information, databases, and ex-
perimental data. The KoxGSC1457 model is composed of
1,457 reactions and 1,099 metabolites (Additional file 1
and Additional file 2). The model was carefully examined
by in silico analyses for genetic and environmental pertur-
bations. The in silico analysis using the model predicted
that the pyruvate pool is mostly important for 2,3-BD syn-
thesis, and this was verified by fermentation of the ldhA
gene knockout mutant. Also, the model showed that the
availability of oxygen strongly affected the production of
2,3-BD by K. oxytoca.Results and discussion
Genome-scale reconstruction and general features of K.
oxytoca metabolic network
The metabolic network of K. oxytoca was initially recon-
structed based on genome annotation information and
metabolic pathway databases [32,33]. The reconstructed
metabolic network was further refined by comparing it
with experimental data and incorporating biomass for-
mation reactions. The composition of biomass compo-
nents, including carbohydrates, amino acids, and lipids,
was experimentally determined using cells collected in
the mid-exponential growth phase (Additional file 1 and
Additional file 3). After validation of the genome-scale
metabolic model of K. oxytoca (KoxGSC1457) was com-
pleted, 1,457 metabolic reactions and 1,099 metabolites
were included in the final construction (Figure 1 and 2,
Table 1 and Additional file 1 and Additional file 2). The
KoxGSC1457 model consists of 1,228 intracellular meta-
bolic reactions and 229 transport reactions. 19.57% of
the total open reading frames (ORFs), corresponding to1,074 genes of 5,488 ORFs, was incorporated into the
model (Table 1).
The metabolic reactions in KoxGSC1457 were classified
into 8 different subsystems, comprising 97 sub-metabo-
lisms: amino acid metabolism, carbohydrate metabolism,
metabolism of cofactors and vitamins, nucleotide metabo-
lism, lipid metabolism, energy metabolism, transporters,
and others (Figure 2 and Additional file 1). Figure 2A
details the numbers and percentages of reactions asso-
ciated with genes for each subsystems. Amino acid meta-
bolism ranks as the largest subsystem in KoxGSC1457,
followed by carbohydrate metabolism. The sum of the
three largest subsystems, amino acid metabolism, carbohy-
drate metabolism, and metabolism of cofactors and vita-
mins, account for more than a half of the total number of
reactions. The percentage of reactions assigned to ORFs
in KoxGSC1457 was 79.7%. The remaining 20.3% of
reactions included in the model contained lumped multi-
step reactions, spontaneous reactions, reactions added to
fill missing links, or several transport reactions (Table 1).
More than 90% of the reactions in 6 subsystems, except
for transporters and energy metabolism are associated
with genes (Figure 2A). Figure 2B and C describe the
classification of genes and metabolites in KoxGSC1457.
The smaller percentages of unique metabolites for each
category compared with those of unique genes imply that
several metabolites participate with reactions in different
subsystems, while most genes function to a specific sub-
system (Figure 2B).
The KoxGSC1457 model contains the reactions for
2,3-BD biosynthesis catalyzed by acetolactate synthase
(E.C. 2.2.1.6), acetolactate decarboxylase (E.C. 4.1.1.5), and
acetoin reductase (E.C. 1.1.1.4). The model also includes a
spontaneous reaction that converts α-acetolactate into
diacetyl (C4H6O2) and CO2 in the presence of oxygen.
Diacetyl can then be catalyzed into acetoin (C4H8O2),
which is the precursor of 2,3-BD, by diacetyl reductase
(E.C. 1.1.1.303). K. oxytoca has its specialty for glycerol
utilization by oxidative and reductive routes. Thus, the
model encompasses the reactions for glycerol utilization,
which are catalyzed by glycerol kinase (E.C. 2.7.1.30) and
glycerol-3-phosphate dehydrogenase (E.C. 1.1.5.3) of the
oxidative route, and NAD-dependent glycerol dehydro-
genase (E.C. 1.1.1.6) and dihydroxyacetone kinase
(E.C. 2.7.1.29) of the reductive route. Finally, the re-
fined KoxGSC1457 model was used to understand the
metabolic characteristics of K oxytoca and was applied
to analyze the strategies for 2,3-BD production.
Effects of increasing the metabolic flux pools of 2,3-BD
precursors in K. oxytoca
K. oxytoca is naturally capable of producing 2,3-BD by
metabolizing various carbon sources such as lactose, ga-
lactose, glucose, xylose, and glycerol [9,10,13-16,18]. 2,3-
Figure 1 Schematic processes of genome-scale metabolic model reconstruction for K. oxytoca. (1-2-3) Reconstruction of metabolic
network using genome annotation data. (3-6-7-2 or 4-5-7-2) Manual curation and model refinement of metabolic network based on literatures,
databases, gene-protein-reaction correlation, comparative genome analysis, error corrections, and gap filling. (8-9-10) Model validation by
comparing with experimental data and determination of biomass composition to be applied to the model. (11–12) Strain improvement and
metabolic engineering by combining with in silico simulation and analysis. The thick and black arrows indicate the main process for model
reconstruction. The thin and gray arrows indicated the process of model refinement and improvement.
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the budB, budA, and budC genes in a operon [2,34]. Two
pyruvates from glycolysis are converted to 2-acetolactate
by releasing CO2 (budB). 2-acetolactate is then trans-
formed into acetoin by decarboxylation to CO2 (budA).
2,3-BD is then synthesized from acetoin with oxidation of
NADH into NAD+ by acetoin reductase (budC) (Figure 3).
For the synthesis of one mole of 2,3-BD from pyruvate,
two moles of CO2 are released and one mole of NADH is
oxidized. The respective reactions for 2,3-BD synthesis are
reflected in the KoxGSC1457 model. The model was then
employed to design the strategy of 2,3-BD overproduction
and to understand its metabolic characteristics.Firstly, the flux solution space of the wild-type strain
of K. oxytoca correlated with cell growth, 2,3-BD pro-
duction, and byproducts formation rates were analyzed
in order to understand the current state of the wile-type
by constraints-based flux analysis simulation using
KoxGSC1457 (Figure 3A). As the first priority of cells is
survival, the maximal point of an in silico cell growth rate
is generally used to predict the actual state of a cell
[35-37], which is indicated by an arrow in Figure 3.
Byproducts include ethanol and several organic acids,
such as lactic acid, acetic acid, succinic acid, and formic
acid. The model predicted that the wild-type strain of K.
oxytoca produces 2,3-BD along with large amounts of
Figure 2 Metabolic network properties of KoxGSC1457. (A) The number of reactions in each of 8 functional categories. The percentages
mean the ratio of reactions assigned with genes. (B) The number of genes in each category. The percentages mean the ratio of genes unique to
each category. (C) The number of metabolites in each category. The percentages mean the ratio of metabolites unique to each category.
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previous studies that the wild-type strains yielded not
only 2,3-BD but also lactic acid, formic acid, and ethanol
as fermentation end-products (Figure 4C) [9,10,19].
Thus, genetic manipulations like gene knockout haveTable 1 Features of the in silico genome-scale metabolic
model of K. oxytoca
Features Number
Genome feature
Genome size (base pairs, bp)
Chromosome 1 5,974,109 (56.05)a
No. of open reading frames (ORFs)
Chromosome 1 5,488
In silico metabolic model
No. of reactions (redundant) included in the model 1,457
No. of biochemical reactions 1,228
No. of transport reactions 229
No. of reactions (unique) included in the model 1,437
No. of metabolites 1,099
No. of ORFs assigned in metabolic network 1,074
ORF coverageb (%) 19.57
aThe parenthesis includes the value of G + C content (%).
bThe number of ORFs participated in the KoxGSC1457 model divided by the
total number of ORFs in the K. oxytoca genome.been attempted to prevent the formation of byproducts
in order to enhance 2,3-BD production [9,13].
Likewise, the KoxGSC1457 model was used to exa-
mine the importance of 2,3-BD precursors, and it gave
better insights into augmenting the metabolic flux pools
of 2,3-BD precursors for 2,3-BD overproduction (Figure 3B
and C). In order to increase the metabolic flux pools of
2,3-BD precursors as well as to investigate its effects on
2,3-BD overproduction, all reactions participating in the
consumption of target precursors were eliminated except
for reactions involved in 2,3-BD biosynthetic pathways
and essential reactions required for cell growth on the
basis of the wild-type strain of KoxGSC1467, as described
in Figure 3B. Accordingly, the flux solution spaces were
scanned by increasing the flux pool of each precursor
(Figure 3C). As a result, increasing the pools of most pre-
cursors had no effects on the production of 2,3-BD com-
pared to that of the wild-type strain, as determined
through comparison of the flux solution spaces. The
model predicted that the surplus fluxes from artificially in-
creased flux pools of most 2,3-BD precursors were not
redirected to 2,3-BD synthesis but went toward other
pathways for survival related with biomass synthesis, such
as amino acids, nucleotides, lipids, and cofactors, prior to
arriving at 2,3-BD biosynthetic reactions. In some cases,
artificially increasing the flux pool of a 2,3-BD precursor
(e.g. phosphoenolpyruvate) had negative influences on
Figure 3 Effects of increasing the metabolic flux pools of precursors for 2,3-BD production in K. oxytoca. (A) 3D mesh plot graph as a
continuous surface for in silico flux solution space of K. oxytoca wild-type strain correlated with cell growth rate, byproducts formation rate, and
2,3-BD production rate and its corresponding contour graph. (B) Method to examine the effects of increasing the metabolic flux pools of 2,3-BD
precursors. In order to increase the metabolic flux pools of 2,3-BD precursors, all reactions that consume the target precursor were eliminated
except for reactions that exist in 2,3-BD biosynthetic pathway and essential reactions for growth on the basis of the wild-type strain of
KoxGSC1457. Because the first priority of a actual cell is survival, the maximal point of in silico cell growth rate is generally useful to predict the
actual state of a cell, which is indicated by an arrow. Byproduct contains ethanol and several organic acids: lactic acid, acetic acid, succinic acid,
and formic acid. (C) Schematic metabolic pathway related with 2,3-BD production and 3D mesh plot graphs as a continuous surface for in silico
flux solution spaces of cases that increase each metabolic flux pool of 2,3-BD precursors and its corresponding contour graphs. The colors
changed by gradation in graph indicate the value of cell growth rate. The red color means larger value of cell growth rate than other colors.
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precursor requirements for biomass synthesis. However, if
the pyruvate pool was augmented sufficiently, the flux so-
lution space was altered so that KoxGSC1457 was enabled
to overproduce 2,3-BD by lowering byproducts formation
rates at an optimal cell growth rate (Figure 3C). The sur-
plus of the pyruvate pool was sufficiently redirected to
2,3-BD synthesis, resulting in an approximate doubling of
the 2,3-BD production rate. Correspondingly, byproducts
formation rates decreased dramatically compared with
those of the wild-type strain, and consequently, augmenta-
tion of the pyruvate pool is one of most important keys
for 2,3-BD overproduction.In silico single gene knockout simulation and changes of
flux solution space by ldhA gene knockout in K. oxytoca
During fermentation by the K. oxytoca wild-type strain,
several byproducts, including lactic acid, ethanol, and for-
mic acid were produced (Figure 4). For the overproduc-
tion of 2,3-BD in K. oxytoca by reducing the formation of
byproducts and redirecting the remaining metabolic fluxes
towards the synthesis of 2,3-BD, in silico single gene
knockout simulation was performed using flux balance
analysis (FBA). As a result, the knockout of ldhA gene en-
coding lactate dehydrogenase, which converts pyruvate
into lactic acid with NADH oxidation, was targeted with
top priority for a single gene knockout strategy based on
Figure 4 Flux solution spaces and batch fermentation results of wild-type and mutant (ΔldhA) strains of K. oxytoca. (A) 3D mesh plot
graph as a continuous surface for in silico flux solution space of K. oxytoca wild-type strain correlated with cell growth rate, byproducts formation
rate, and 2,3-BD production rate and its corresponding contour graph. (B) 3D mesh plot graph as a continuous surface for in silico flux solution
space of ldhA gene knockout mutant of K. oxytoca correlated with cell growth rate, byproducts formation rate, and 2,3-BD production rate and its
corresponding contour graph. The colors changed by gradation in graph indicate the value of cell growth rate. The red color means larger value
of cell growth rate than other colors. (C) Batch fermentation result of K. oxytoca wild-type strain. (D) Batch fermentation result of ldhA gene
knockout mutant of K. oxytoca. The arrow indicates the position of in silico optimal cell growth rate. Based on the flux solution space of wild-type
strain, the large amount of byproducts were produced during 2,3-BD production. After in silico knockout of ldhA gene, byproducts formation rate
was decreased, while 2,3-BD production rate was increased in comparison with wild-type strain. The fermentation was performed at 150 rpm,
pH 6.5, and 37°C in 3 L working volume. The symbols in fermentation profiles indicates the concentration of glucose (○), 2,3-BD (●), OD600 (■),
ethanol (▲), succinic acid (♦), lactic acid (*), formic acid (◊), and acetic acid (Δ).
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and minimization of byproducts formation rates. Then,
the KoxGSC1457 model investigated the metabolic cha-
racteristics of the ldhA gene knockout mutant by exami-
ning the changes of flux solution space compared with
those of the wild-type strain (Figure 4A and B). In
the wild-type strain, the model predicted that K. oxytoca
produces large amounts of byproducts along with 2,3-BD.
In the ldhA gene knockout mutant, the optimal point
shifted to an increase of 2,3-BD production but to a de-
creased formation of byproducts, including lactic acid.
ldhA gene knockout significantly increased the pyruvate
pool that redirected the metabolic flux to 2,3-BD synthe-
sis. This prediction was validated by batch fermentations
of K. oxytoca wild-type and ldhA gene knockout strains
(Figure 4C and D). K. oxytoca wild-type strain produced
32 g/L of lactic acid and 17 g/L of 2,3-BD by consuming
90 g/L of glucose. However, the ldhA gene knockout mu-
tant dramatically decreased lactic acid production to
1.9 g/L, which is about 6% of that produced by the wild-
type strain (Figure 4D). Accordingly, 2,3-BD production in
the mutant was increased to about 30 g/L, which is about
176% of that produced by the wild-type strain. However,
cell growth and glucose uptake rates of the ldhA gene
knockout mutant were maintained in comparison with
those of the wild-type strain because the redox balance of
NAD+/NADH was not disrupted (Figure 4C and D). The
deletion of lactate dehydrogenase forming lactic acid with
the oxidation of NADH seemed to be compensated with
2,3-BD dehydrogenase, producing 2,3-BD with the oxida-
tion of NADH as well, which made 2,3-BD production
increase without any retardation of growth. When we
compared the in silico flux solution space of the ldhA gene
knockout mutant in Figure 4B with that of the increasing
highly pyruvate pool in Figure 3C, more improvements for
2,3-BD overproduction could be made by further genetic
manipulation. In particular, the fermentation results of the
ldhA gene knockout mutant in Figure 4D suggests the
construction of a mutant preventing the formation of
ethanol, formic acid, and succinic acid. For this, the
KoxGSC1457 model will be applicable to identify sui-
table candidates for further genetic manipulations.
Effects of varying oxygen uptake rate for 2,3-BD
production in K. oxytoca
For 2,3-BD production by K. oxytoca, the dissolved oxygen
(DO) level in medium is known as one of the most im-
portant environmental factors [21-23]. In order to gain an
insight into the effect of oxygen uptake rate on 2,3-BD
production in K. oxytoca, the oxygen uptake rate was
perturbed by constraints-based flux analysis between 0
and 30 mmol/gDCW (gram dry cell weight)/h and glucose
uptake rate was fixed to 10 mmol/gDCW/h, with max-
imization and minimization of 2,3-BD production rate asthe objective function (Figure 5A). As shown in Figure 5A,
the predicted 2,3-BD production rate increased as the oxy-
gen uptake rate was raised to 5 and 10 mmol/gDCW/h.
On the other hand, the 2,3-BD production rate grad-
ually decreased with further increasing oxygen uptake
rate (Figure 5A).
This simulation was validated by batch fermentation
experiments under different agitation speeds (rpm) and
DO levels (Figure 5B and C). The agitation speeds were
a150, 250, 350, 450, 550, 650, and 750 rpm. DO levels
were maintained at 5% and 10% by automatically ad-
justing the agitation speed between 50 and 1,000 rpm.
The aeration rate was set at 1 vvm (air volume∙ working
volume-1∙ minute-1) during the whole period of fermen-
tation. The fermentations were performed by using the
ldhA gene knockout mutant of K. oxytoca, as the most
productive 2,3-BD producer up to this point. As a result,
the final 2,3-BD concentration (g/L) and yield (g/g glu-
cose) increased through increasing the agitation speed to
350 rpm, but further increasing agitation speed caused a
decrease of the final 2,3-BD concentration and yield.
Meanwhile, the maximal value of 2,3-BD productivity of
2.1 g/L/h was observed at 450 rpm. The highest glucose
consumption was observed at 550 rpm, however, most
consumption of carbon source was used to synthesize
not 2,3-BD but biomass at 550 rpm and agitation speeds
greater than 550 rpm. In addition, fermentation at 10%
DO level showed less 2,3-BD concentration, yield, and
productivity than at 5% DO. These results are a strong
indication that excessive oxygen exposure during fer-
mentation impairs 2,3-BD overproduction. Since the op-
timal oxygen level exists beyond the scope of DO as
represented in Figure 5, it is recommended to adjust the
agitation speed depending on cellular status for 2,3-BD
overproduction. These observations were also supported
by a previous study, in which the optimal agitation speed
existed on 2,3-BD production [10].
Conclusions
K. oxytoca is a promising microorganism which has
great potential in the industrial production of 2,3-BD.
To make the better use of this organism and to improve
industrial applicability, we constructed a genome-scale
metabolic model of K. oxytoca, KoxGSC1457, consisting
of 1,457 reactions and 1,099 metabolites based on infor-
mation obtained from genome annotation data, data-
base, literature and validation experiments. Using the
KoxGSC1457 model, in silico metabolic fluxes were ana-
lyzed to investigate the effects of environmental and ge-
netic variation. First, the effects of increasing the
metabolic flux pools of 2,3-BD precursors were examined
to understand the most important precursor to be aug-
mented for 2,3-BD overproduction. In silico single gene
knockout simulation was then performed to identify gene
Figure 5 Effects of varying oxygen uptake rate for 2,3-BD production. (A) In silico prediction to examine the response of 2,3-BD production
rate to varying oxygen uptake rate from 0 to 30 mmol/gDCW/h. (B) Fermentation profiles for different agitation speeds (150, 250, 350, 450, 550,
650, and 750 rpms) and DO levels (5% and 10%) in ldhA gene knockout mutant of K. oxytoca. The open circle (○), filled circle (●), and filled
square (■) indicate the concentrations of glucose, 2,3-BD, and OD600, respectively. (C) Summary of fermentation results that include ending time
of fermentation (hour), final DCW (g/L), 2,3-BD concentration (g/L), yield (g/g glucose), and productivity (g/L/h).
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mation, and the change of flux solution space was then
analyzed by elimination of ldhA gene resulting in the
K. oxytoca ldhA gene knockout mutant, which is one of
organisms that shows best performance for 2,3-BD pro-
duction so far. Finally, to design strategies for better
2,3-BD overproduction, in silico metabolic flux analyses of
KoxGSC1457 were executed to examine the effects of
varying oxygen uptake rate during 2,3-BD production, and
to determine the optimal agitation speed. Through the
successful use of the KoxGSC1457 genome-scale meta-
bolic model like those, it gave us the confidence that the
model was thoroughly validated in comparison with va-
rious experimental data. There are still many difficulties
associated with the overall economics of producing
2,3-BD through K. oxytoca on an industrial scale.
Hence, it is expected that the model constructed in this
study will support us to understand cellular physiology on
systems level, broaden our insight on this organism, and
conquer problems more systematically.
Methods
Reconstruction of genome-scale metabolic model
Physiological data and biochemical reactions of K.
oxytoca were collected from various sources, such as ex-
periments, literatures, and public databases, in order to
reconstruct the genome-scale metabolic model of K.
oxytoca. First, information of genome annotation was
gained from genome data in NCBI (http://www.ncbi.
nlm.nih.gov/). Then, the biochemical reactions of K.
oxytoca were assembled from various literatures, experi-
ments, and public databases, including the Kyoto
Encyclopedia of Genes and Genomes (KEGG, [32]),
Biocyc [33], Metacyc [33], TCDB [38], and TransportDB
[39]. Second, the draft version of the metabolic model
was manually curated and refined based on experimen-
tation, literature, databases, gene-protein-reaction corre-
lations, comparative genome analysis, error corrections,
and gap filling. Third, the refined model was validated
through comparison with experimental data, including
fermentation data. The biomass composition data of K.
oxytoca were then analyzed and applied to the model.
Finally, the validated model was used to analyze the
physiology of K. oxytoca and to apply to in silico simula-
tions for strain improvement and fermentation opti-
mization (Figure 1).
Biomass composition
The composition of biomass components was experimen-
tally measured to construct the biomass formation reac-
tions of K. oxytoca more accurately. The cells of K.
oxytoca were cultured in minimal culture medium con-
taining no yeast extract, and the samples were collected in
the mid-exponential growth phase. The carbohydratecompositions were determined for neutral and amino
sugars (Korea Basic Science Institute, Daejeon, Korea).
The neutral and amino sugars were extracted from cells
by treating them with 2 M trifluoroacetic acid and 6 N
HCl, respectively, at 100°C for 4 hours. The carbohydrates
were analyzed by ICD-5000 (Dionex, Sunnyvale, CA,
USA) equipped with a CarboPac PA10 column (4.5 ×
250 mm, Dionex) and a CarboPac PA10 cartridge (4 ×
50 mm). 16 mM NaOH was used as a mobile phase with
a flow rate of 1.0 mL∙ min-1. Then, data were analyzed by
Chromelon ver 6.8 software. Amino acid compositions
were analyzed by a Hewlett Packard 1100 series HPLC
systems equipped with Waters Nova-Pak C18 4 um
column (3.9 × 300 mm) (Korea Basic Science Institute,
Daejeon, Korea). The fatty acid composition of K. oxytoca
was determined by Sherlock microbial identification sys-
tem of Sherlock version 6.1 (Korea Research Institute of
Bioscience and Biotechnology, Daejeon, Korea). DNA and
RNA compositions were analyzed based on genome infor-
mation of K. oxytoca. The DNA composition was calcu-
lated by using the GC content (53%) of K. oxytoca. The
RNA composition was calculated based on nucleotide
sequences for rRNA and tRNA derived from genome
information. The compositions for other components
were obtained from literature or assumed reasonably
described in Additional file 3.
Constraints-based flux analysis
In order to perform in silico simulations, and to predict
the metabolic characteristics of K. oxytoca, constraints-
based flux analysis, including FBA, was carried out under
the assumption of a pseudo-steady state [35,40-43]. In
order to simulate the in silico model more accurately, the
limits of uptake and secretion rates for some metabolites,
including amino acids and organic acids such as acetic
acid, ethanol, formic acid, lactic acid, pyruvic acid, and
succinic acid, were constrained by experimentally mea-
sured flux values. Likewise, the limits related with secre-
tion for some metabolites, which were not produced
during fermentation such amino acids, were constrained
to zero.
The effect of 2,3-BD production rate in response to
varying oxygen uptake rate was examined by flux response
analysis [44-46]. The 2,3-BD production rate, as objective
function, was maximized and minimized according to the
changes of oxygen uptake rate from 0 to 30 mmol/
gDCW/h with a 10 mmol/gDCW/h glucose uptake rate.
Fermentation
For seed preparation, suspended cells from single colonies
on Luria-Bertani (LB) agar (Difco Laboratories, Detroit,
MI) plates were precultured in 20 mL test tubes con-
taining 5 mL culture medium at 37°C for 5 h. 1 mL ali-
quots of the preculture were then transferred to 500 mL
Park et al. Microbial Cell Factories 2013, 12:20 Page 10 of 11
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and the cells were cultivated to an optical density of 1.5 ~
2.0 at 600 nm (OD600). The tube and flask cultivations
were placed in a rotary shaker at 150 rpm and 37°C (JEIO
Tech. Co. SI-900R). The culture medium contained per
liter: yeast extract (Becton Dickinson, Le Pont de Claix,
France), 5 g; FeSO4 · 7H2O, 0.05 g; ZnSO4 · 7H2O, 0.001 g,
MnSO4 · H2O, 0.001 g; CaCl2∙ 2H2O, 0.001 g; MgSO4∙
7H2O, 0.25 g; (NH4)2SO4, 6.6 g; K2HPO4, 8.7 g; KH2PO4,
6.8 g; trace metal solution, 10 mL. The trace metal solu-
tion contains per liter: FeSO4∙ 7H2O, 5 g; ZnSO4∙ 7H2O,
0.1 g; MnSO4∙ H2O, 0.1 g; CaCl2∙ 2H2O, 0.1 g; HCl 10 mL.
Batch fermentations were performed in a 5-L BIOFLO
& CELLIGEN 310 bioreactor (New Brunswick. Scientific
Co., Edison, NJ) with 3 L culture medium containing
90 g/L of D-glucose and 300 mL seed culture. The fer-
menter was continuously aerated through a 0.2 μm mem-
brane filter at a flow rate of 1 vvm (air volume∙ working
volume-1∙ minute-1). The temperature was maintained at
37°C. The pH was controlled at 6.5 ± 0.1 by the automatic
feeding of 5 N NaOH. Foaming was controlled by the
addition of Antifoam 289 (Sigma, St. Louis, MO). For bio-
mass composition analysis, the cells were cultured in a
medium in which only yeast extract was removed from
the culture medium. All fermentations were performed at
least three times independently, and the representative
results are shown in Figures.Analytical procedures
The concentrations of D-glucose and metabolites, includ-
ing 2,3-BD, formic acid, ethanol, acetic acid, lactic acid,
succinic acid, and acetoin, were determined by a high-
performance liquid chromatography equipped with UV/
VIS and RI detectors (Agilent 1260 series, Agilent Tech-
nologies, Waldbronn, Germany). An Aminiex HPX-87H
column (300 mm× 7.8 mm, Bio-Rad, Hercules, CA) was
isocratically eluted with 0.01 N H2SO4 at 80°C and a flow
rate of 0.6 mL/min. The OD600 was measured using a
UV–vis spectrophotometry (DR5000, Hach Company,
CO) to monitor cell growth. Cell concentration, DCW per
liter of culture broth, was calculated from the pre-
determined standard curve relating OD600 to DCW
(1 OD600 = 0.3877 ± 0.0136 g DCW∙ L
-1). DCW was deter-
mined by filtering the culture broth through a 0.45 μm
membrane and washing it twice with an equal volume of
deionized distilled water. The filtered cells were then dried
at 80 ± 5°C overnight and cooled to room temperature in
a desiccator prior to weighting.Additional files
Additional file 1: List of metabolic reactions in the genome-scale
metabolic model of Klebsiella oxytoca.Additional file 2: List of metabolites in the genome-scale metabolic
model of Klebsiella oxytoca.
Additional file 3: Biomass composition of Klebsiella oxytoca.
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